Case Report: Pregnant ROS1+ lung cancer patient treated with crizotinib - Impact on infancy.
Saved in:
| Title: | Case Report: Pregnant ROS1+ lung cancer patient treated with crizotinib - Impact on infancy. |
|---|---|
| Authors: | Weber T; Marburg University, Department of Medicine, Marburg, Germany.; Department of Hematology, Oncology, and Immunology, University Hospital Giessen and Marburg, Marburg, Germany., Hoffmann J; Marburg University, Department of Medicine, Marburg, Germany.; Department of Hematology, Oncology, and Immunology, University Hospital Giessen and Marburg, Marburg, Germany., Michel C; Marburg University, Department of Medicine, Marburg, Germany.; Department of Hematology, Oncology, and Immunology, University Hospital Giessen and Marburg, Marburg, Germany., Burchert A; Marburg University, Department of Medicine, Marburg, Germany.; Department of Hematology, Oncology, and Immunology, University Hospital Giessen and Marburg, Marburg, Germany., Pesek J; Marburg University, Department of Medicine, Marburg, Germany.; Core Facility for Metabolomics, Marburg, Germany., Taudte RV; Marburg University, Department of Medicine, Marburg, Germany.; Core Facility for Metabolomics, Marburg, Germany., Schoner K; Marburg University, Department of Medicine, Marburg, Germany.; Institute of Pathology, Fetal Pathology, University Hospital Giessen and Marburg, Marburg, Germany., Bartos H; Marburg University, Department of Medicine, Marburg, Germany.; Clinic of Diagnostic and Interventional Radiology, University Hospital Giessen and Marburg, Marburg, Germany., Viniol S; Marburg University, Department of Medicine, Marburg, Germany.; Clinic of Diagnostic and Interventional Radiology, University Hospital Giessen and Marburg, Marburg, Germany., Weiland P; Marburg University, Department of Medicine, Marburg, Germany.; Department of Hematology, Oncology, and Immunology, University Hospital Giessen and Marburg, Marburg, Germany., Neubauer A; Marburg University, Department of Medicine, Marburg, Germany.; Department of Hematology, Oncology, and Immunology, University Hospital Giessen and Marburg, Marburg, Germany., Flommersfeld S; Marburg University, Department of Medicine, Marburg, Germany.; Center for Transfusion Medicine and Hemotherapy, University Hospital Giessen and Marburg, Marburg, Germany., Köhler S; Marburg University, Department of Medicine, Marburg, Germany.; Department of Gynecology, Prenatal Medicine and Fetal Therapy, University Hospital Giessen and Marburg, Marburg, Germany., Jung M; Marburg University, Department of Medicine, Marburg, Germany.; Department of Pediatrics, University Hospital Giessen and Marburg, Marburg, Germany., Weber S; Marburg University, Department of Medicine, Marburg, Germany.; Department of Pediatrics, University Hospital Giessen and Marburg, Marburg, Germany., Hornig S; Marburg University, Department of Medicine, Marburg, Germany.; Department of Pediatrics, University Hospital Giessen and Marburg, Marburg, Germany., Wallot I; Marburg University, Department of Medicine, Marburg, Germany.; Department of Pediatrics, University Hospital Giessen and Marburg, Marburg, Germany. |
| Source: | Frontiers in oncology [Front Oncol] 2026 Mar 10; Vol. 16, pp. 1784859. Date of Electronic Publication: 2026 Mar 10 (Print Publication: 2026). |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2234-943X |
|---|---|
| DOI: | 10.3389/fonc.2026.1784859 |
